The FDA’s regulatory process is the major reason and a report calls it a threat to investment to U.S. medical innovation.
Read this article:
VCs to Stem Med-Tech Investment
If you enjoyed this post, make sure you subscribe to my RSS feed!
The FDA’s regulatory process is the major reason and a report calls it a threat to investment to U.S. medical innovation.
Read this article:
VCs to Stem Med-Tech Investment
Tagged with: america arlington chairwoman entrepreneurs european financial health imperative innovation investment kleiner-perkins medical obama report